Paul Tudor Jones’s CareDx CDNA Stock Holding History

Paul Tudor Jones’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$736K	Buy	+25,842	New	+$563K	﹤0.01%	2610
2025 Q2	–	Sell	-12,503	Closed	-$222K	–	3304
2025 Q1	$222K	Sell	12,503 -12,286	-50%	-$265K	﹤0.01%	2802
2024 Q4	$531K	Sell	24,789 -3,610	-13%	-$87.8K	﹤0.01%	2192
2024 Q3	$887K	Buy	28,399 +7,473	+36%	+$186K	﹤0.01%	1697
2024 Q2	$325K	Buy	+20,926	New	+$253K	﹤0.01%	1985
2023 Q4	–	Sell	-11,506	Closed	-$80.5K	–	2409
2023 Q3	$80.5K	Buy	+11,506	New	+$106K	﹤0.01%	2162
2023 Q2	–	Sell	-48,227	Closed	-$441K	–	2475
2023 Q1	$441K	Buy	+48,227	New	+$617K	0.01%	1691
2021 Q4	–	Sell	-8,370	Closed	-$530K	–	2446
2021 Q3	$530K	Buy	8,370 +5,325	+175%	+$406K	0.01%	1613
2021 Q2	$279K	Sell	3,045 -10,318	-77%	-$820K	0.01%	1376
2021 Q1	$910K	Buy	+13,363	New	+$1.04M	0.02%	883

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paul Tudor Jones's CDNA Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in CareDx (CDNA) in Q2 2026: 25,842 shares worth $736K. The stake represents ﹤0.01% of the portfolio and ranks #2610 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in CDNA as recently as Q1 2025.

Paul Tudor Jones first reported a position in CDNA in Q1 2021 and has held it in 10 quarters since. The position peaked at $910K in Q1 2021. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Paul Tudor Jones held 25,842 shares of CareDx worth $736K as of Q2 2026.
CareDx was a new Paul Tudor Jones position in Q2 2026.
CareDx made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2610 holding.
Paul Tudor Jones first reported a position in CareDx in Q1 2021 and has held it in 10 quarters since.
Paul Tudor Jones's CareDx position peaked at $910K in Q1 2021.
225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.